Digital resources in the Social Sciences and Humanities OpenEdition Our platforms OpenEdition Books OpenEdition Journals Hypotheses Calenda Libraries OpenEdition Freemium Follow us

CRISPR-Molekülbaukasten: Wieso kein Commons für Patente?

Was alle bezahlt haben, sollen alle nutzen können. Das ist das Steuerzahler-Argument für Open Access. Wieso sollte das nicht auch für öffentlich geförderte Forschung gelten, die zu Patenten führt?

Yarden Katz im Boston Review zum Streit um die CRISPR-Patente:

[W]e should imagine a way to distribute research products that considers the ethical and social responsibilities of scientists to the public. We can take a leaf from the software world’s book and sketch a free biology (as in “free software”) that respects these responsibilities. This will require new mechanisms for describing research ownership and sharing that are in the public interest and that support the university’s research branch.

In thinking about how to correct the patenting system’s violation of the commons, Yochai Benkler has proposed that research communities adopt open, “publicly minded” licensing of the sort used in the software field. This would allow academics to change the way their work may be used without having to wait for legal reforms. These commons-based licenses can also explicitly allow for humanitarian applications of research and technology, which are otherwise largely sidelined by private ownership. As Benkler noted, coordinated adoption by researchers of such mechanisms would give universities “substantial negotiating power with the biotechnology and pharmaceuticals industries.”
https://bostonreview.net/books-ideas/yarden-katz-who-owns-molecular-biology?Src=longreads

Via
https://www.perlentaucher.de/magazinrundschau/2015-11-10.html (dort weitere informative Links zu CRISPR)

Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA.jpg
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA” by Hiroshi Nishimasu, F. Ann Ran, Patrick D. Hsu, Silvana Konermann, Soraya I. Shehata, Naoshi Dohmae, Ryuichiro Ishitani, Feng Zhang, and Osamu Nureki – Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA http://dx.doi.org/10.1016/j.cell.2014.02.001. Licensed under CC BY-SA 3.0 via Commons.


OpenEdition schlägt Ihnen vor, diesen Beitrag wie folgt zu zitieren:
Klaus Graf (22. November 2015). CRISPR-Molekülbaukasten: Wieso kein Commons für Patente? Archivalia. Abgerufen am 24. April 2025 von https://doi.org/10.58079/beun


Autor: Klaus Graf

Historiker und Archivar, Blogger

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert

This site uses Akismet to reduce spam. Learn how your comment data is processed.